INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Inpersol-zm W/ Dextrose 2.5% In Plastic Container, and what generic alternatives are available?
Inpersol-zm W/ Dextrose 2.5% In Plastic Container is a drug marketed by Fresenius Medcl and is included in one NDA.
The generic ingredient in INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER is calcium chloride; dextrose; sodium chloride; sodium lactate. There are two hundred and eighty-two drug master file entries for this compound. Additional details are available on the calcium chloride; dextrose; sodium chloride; sodium lactate profile page.
Summary for INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
US Patents and Regulatory Information for INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Medcl | INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER | calcium chloride; dextrose; sodium chloride; sodium lactate | SOLUTION;INTRAPERITONEAL | 019395-002 | Mar 26, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |